[1] Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain. Nature, 1988; 332, 78-81. doi:  10.1038/332078a0
[2] Tamura N, Ogawa Y, Yasoda A, et al. Two cardiac natriuretic peptide genes (atrial natriuretic peptide and brain natriuretic peptide) are organized in tandem in the mouse and human genomes. J Mol Cell Cardiol, 1996; 28, 1811-5. doi:  10.1006/jmcc.1996.0170
[3] Sudoh T, Maekawa K, Kojima M, et al. Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide. Biochem Biophys Res Commun, 1989; 159, 1427-34. doi:  10.1016/0006-291X(89)92269-9
[4] Gunning M, Ballermann BJ, Silva P, et al. Brain natriuretic peptide: interaction with renal ANP system. Am J Physiol, 1990; 258, F467-72. http://ajprenal.physiology.org/content/258/3/F467
[5] St Pierre L, Flight S, Masci PP, et al. Cloning and characterisation of natriuretic peptides from the venom glands of Australian elapids. Biochimie, 2006; 88, 1923-31. doi:  10.1016/j.biochi.2006.06.014
[6] Scott NJ, Ellmers LJ, Lainchbury JG, et al. Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development. Biochim Biophys Acta, 2009; 1792, 1175-84. doi:  10.1016/j.bbadis.2009.09.009
[7] Thejus J, Francis J. N-terminal pro-brain natriuretic peptide and atrial fibrillation. Indian Pacing Electrophysiol J, 2009; 9, 1-4. http://www.oalib.com/paper/2468364#.WWwlIflJJpY
[8] Liang F, O'Rear J, Schellenberger U, et al. Evidence for functional heterogeneity of circulating B-type natriuretic peptide. J Am Coll Cardiol, 2007; 49, 1071-8. doi:  10.1016/j.jacc.2006.10.063
[9] Lam CS, Burnett JC Jr, Costello-Boerrigter L, et al. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population. J Am Coll Cardiol, 2007; 49, 1193-202. doi:  10.1016/j.jacc.2006.12.024
[10] Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive aminoterminal pro-brain natriuretic-proBNP): a new marker of cardiac impairment. Clin Endocrinol, 1997; 47, 287-97. doi:  10.1046/j.1365-2265.1997.2361058.x
[11] Sabatasso S, Vaucher P, Augsburger M, et al. Sensitivity and specificity of NT-proBNP to detect heart failure at post mortem examination. Int J Leg Med, 2011; 125, 849-56. doi:  10.1007/s00414-011-0581-6
[12] Zhang J, Shu YG. Highly sensitive detection of NT-proBNP by molecular motor. Genes & Diseases, 2017; 4, 37-40. https://www.researchgate.net/publication/310839036_Highly_sensitive_detection_of_NT-proBNP_by_molecular_motor
[13] Gunning M, Brenner BM. Urodilatin: a potent natriuretic peptide of renal origin. Curr Opin Nephrol Hypertens, 1993; 2, 857-62. doi:  10.1097/00041552-199311000-00001
[14] Yang H, Li D, He R, et al. A novel quantum dots-based point of care test for syphilis. Nanoscale Res Lett, 2010; 5, 875-81. doi:  10.1007/s11671-010-9578-1
[15] Shen H, Yuan H, Niu JZ, et al. Phosphine-free synthesis of high-quality reverse type-I ZnSe/CdSe core with CdS/Cd(x)Zn(1 -x)S/ZnS multishell nanocrystals and their application for detection of human hepatitis B surface antigen. Nanotechnology, 2011; 22, 375602. doi:  10.1088/0957-4484/22/37/375602
[16] Worsley GJ, Attree SL, Noble JE, et al. Rapid duplex immunoassay for wound biomarkers at the point-of-care. Biosens Bioelectron, 2012; 34, 215-20. doi:  10.1016/j.bios.2012.02.005
[17] Nabatiyan A, Baumann MA, Parpia Z, et al. A lateral flow-based ultra-sensitive p24 HIV assay utilizing fluorescent microparticles. J Acquir Immune Defic Syndr, 2010; 53, 55-61. doi:  10.1097/QAI.0b013e3181c4b9d5
[18] Ahn JS, Choi S, Jang SH, et al. Development of a point-of-care assay system for high-sensitivity C-reactive protein in whole blood. Clin Chim Acta, 2003; 332, 51-9. doi:  10.1016/S0009-8981(03)00113-X
[19] Swanson C, D'Andrea A. Lateral flow assay with near-infrared dye for multiplex detection. Clin Chem, 2013; 59, 641-8. doi:  10.1373/clinchem.2012.200360